+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hepatitis Test Solution/Diagnosis Market Research Report by Technology, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904514
  • Report
  • July 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Hepatitis Test Solution/Diagnosis Market will Grow to USD 4,171.41 Million by 2026, at a CAGR of 5.54%

FEATURED COMPANIES

  • Abbott
  • Avantor Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin
  • F. Hoffmann-La Roche Ltd
The Global Hepatitis Test Solution/Diagnosis Market size was estimated at USD 3,018.17 Million in 2020 and expected to reach USD 3,175.21 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.54% to reach USD 4,171.41 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hepatitis Test Solution/Diagnosis to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Hepatitis Test Solution/Diagnosis Market was studied across Enzyme-linked Immunosorbent Assay (ELISA), Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerase Chain Reaction (PCR), and Rapid Diagnostic Tests (RDT).
  • Based on Disease Type, the Hepatitis Test Solution/Diagnosis Market was studied across Hepatitis B (HBV) and Hepatitis C (HCV).
  • Based on Region, the Hepatitis Test Solution/Diagnosis Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hepatitis Test Solution/Diagnosis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hepatitis Test Solution/Diagnosis Market, including Abbott, Avantor Inc., Bio-Rad Laboratories Inc., bioMérieux SA, DiaSorin, F. Hoffmann-La Roche Ltd, FUJIREBIO Inc., Grifols S.A., Ortho Clinical Diagnostics, QIAGEN, Quest Diagnostics Incorporated, and Siemens AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Hepatitis Test Solution/Diagnosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hepatitis Test Solution/Diagnosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hepatitis Test Solution/Diagnosis Market?
4. What is the competitive strategic window for opportunities in the Global Hepatitis Test Solution/Diagnosis Market?
5. What are the technology trends and regulatory frameworks in the Global Hepatitis Test Solution/Diagnosis Market?
6. What is the market share of the leading vendors in the Global Hepatitis Test Solution/Diagnosis Market?
7. What modes and strategic moves are considered suitable for entering the Global Hepatitis Test Solution/Diagnosis Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Avantor Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin
  • F. Hoffmann-La Roche Ltd
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Disease Type Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of hepatitis and increasing geriatric population
5.1.1.2. Changing lifestyle and food consumption habit and excessive consumption of alcohol
5.1.1.3. Increasing awareness about hepatitis by government and non-profit organization
5.1.2. Restraints
5.1.2.1. Side-effects of medication
5.1.2.2. Complexities in testing and diagnosis
5.1.3. Opportunities
5.1.3.1. Rising technological advancements and modernization in the healthcare sector
5.1.3.2. Increase in regulatory approvals, and growing participation of generic drugs manufacturers
5.1.4. Challenges
5.1.4.1. Lack of authoritative directive regarding the testing for hepatitis virus
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Hepatitis Test Solution/Diagnosis Market, by Technology
6.1. Introduction
6.2. Enzyme-linked Immunosorbent Assay (ELISA)
6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4. Polymerase Chain Reaction (PCR)
6.5. Rapid Diagnostic Tests (RDT)

7. Hepatitis Test Solution/Diagnosis Market, by Disease Type
7.1. Introduction
7.2. Hepatitis B (HBV)
7.3. Hepatitis C (HCV)

8. Americas Hepatitis Test Solution/Diagnosis Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Hepatitis Test Solution/Diagnosis Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Hepatitis Test Solution/Diagnosis Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott
12.2. Avantor Inc.
12.3. Bio-Rad Laboratories Inc.
12.4. bioMérieux SA
12.5. DiaSorin
12.6. F. Hoffmann-La Roche Ltd
12.7. FUJIREBIO Inc.
12.8. Grifols S.A.
12.9. Ortho Clinical Diagnostics
12.10. QIAGEN
12.11. Quest Diagnostics Incorporated
12.12. Siemens AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 20. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 22. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. INDONESIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. MALAYSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. PHILIPPINES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. SINGAPORE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. THAILAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: FPNV POSITIONING MATRIX
FIGURE 56. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY REGION, 2018-2026 (USD MILLION)
TABLE 12. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. INDONESIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. MALAYSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. PHILIPPINES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. SINGAPORE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. THAILAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SCORES
TABLE 42. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RANKING
TABLE 45. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott
  • Avantor Inc.
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche Ltd
  • FUJIREBIO Inc.
  • Grifols S.A.
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Siemens AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll